Additionally, noncanonical NFKB signaling through RELB contributes to doxorubicin-induced glycolysis in doxorubicin-resistant diffuse large B-cell lymphoma cell lines (42). The gene discussed is RELB; the disease is diffuse large B-cell lymphoma.